Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'capecitabine' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 66 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cassidy, J
      Xeloda (R) in colorectal cancer

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    2. Fujimoto-Ouchi, K; Tanaka, Y; Tominaga, T
      Schedule dependency of antitumor activity in combination therapy with capecitabine/5 '-deoxy-5-fluorouridine and docetaxel in breast cancer models

      CLINICAL CANCER RESEARCH
    3. Komatsu, T; Yamazaki, H; Shimada, N; Nagayama, S; Kawaguchi, Y; Nakajima, M; Yokoi, T
      Involvement of microsomal cytochrome P450 and cytosolic thymidine phosphorylase in 5-fluorouracil formation from tegafur in human liver

      CLINICAL CANCER RESEARCH
    4. Kuhn, JG
      Fluorouracil and the new oral fluorinated pyrimidines

      ANNALS OF PHARMACOTHERAPY
    5. Hori, T; Kodama, H; Nishimura, S; Hatano, T; Okamura, R; Fujii, K; Kudo, T; Inamoto, T; Sawai, K; Kobayashi, M; Ogawa, H; Yoshimura, N; Hiraoka, M
      A randomized study comparing oral and standard regimens for metastatic breast cancer

      ONCOLOGY REPORTS
    6. Sadahiro, S; Otani, Y; Oya, K; Ike, H; Shimada, H; Yamaguchi, S; Hiki, Y; Fujita, H; Mitomi, T
      Thymidine phosphorylase expression and effect of doxifluridine: A phase IIstudy

      ONCOLOGY REPORTS
    7. Yamamoto, K; Noda, K; Hatae, M; Kudo, T; Hasegawa, K; Nishimura, R; Honjo, H; Yajima, A; Sato, S; Mizutani, K; Yakushiji, M; Terashima, Y; Ochiai, K; Sasaki, H; Ozaki, M
      Effects of concomitant use of doxifluridine, radiotherapy and immunotherapy in patients with advanced cervical cancer

      ONCOLOGY REPORTS
    8. Ishii, R; Takiguchi, N; Oda, K; Koda, K; Miyazaki, M
      Thymidine phosphorylase expression is useful in selecting adjuvant chemotherapy for stage III gastric cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    9. Cunningham, D; James, RD
      Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    10. Twelves, C; Boyer, M; Findlay, M; Cassidy, J; Weitzel, C; Baker, C; Osterwalder, B; Jamieson, C; Hieke, K
      Capecitabine (Xeloda (TM)) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients withadvanced colorectal carcinoma

      EUROPEAN JOURNAL OF CANCER
    11. Johnston, PG; Kaye, S
      Capecitabine: a novel agent for the treatment of solid tumors

      ANTI-CANCER DRUGS
    12. Takeda, Y; Yoshizaki, I; Nonaka, Y; Yanagie, H; Matsuzawa, A; Eriguchi, M
      Docetaxel alone or orally combined with 5-fluorouracil and its derivatives: effects on mouse mammary tumor cell line MM2 in vitro and in vivo

      ANTI-CANCER DRUGS
    13. O'Shaughnessy, JA; Blum, J; Moiseyenko, V; Jones, SE; Miles, D; Bell, D; Rosso, R; Mauriac, L; Osterwalder, B; Burger, HU; Laws, S
      Randomized, open-label, phase II trial of oral capecitabine (Xeloda((R))) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer

      ANNALS OF ONCOLOGY
    14. Villalona-Calero, MA; Blum, JL; Jones, SE; Diab, S; Elledge, R; Khoury, P; Von Hoff, D; Kraynak, M; Moczygemba, J; Kromelis, P; Griffin, T; Rowinsky, EK
      A phase I and pharmacologic study of capecitabine and paclitaxel in breastcancer patients

      ANNALS OF ONCOLOGY
    15. Diasio, RB
      Current status of oral chemotherapy for colorectal cancer

      ONCOLOGY-NEW YORK
    16. Tsukamoto, Y; Kato, Y; Ura, M; Horii, I; Ishitsuka, H; Kusuhara, H; Sugiyama, Y
      A physiologically based pharmacokinetic analysis of capecitabine, a tripleprodrug of 5-FU, in humans: The mechanism for tumor-selective accumulationof 5-FU

      PHARMACEUTICAL RESEARCH
    17. Klecker, RW; Collins, JM
      Thymidine phosphorylase as a target for imaging and therapy with thymine analogs

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    18. Yamamoto, S; Kurebayashi, J; Kurosumi, M; Kunisue, H; Otsuki, T; Tanaka, K; Sonoo, H
      Combined effects of docetaxel and fluoropyrimidines on tumor growth and expression of interleukin-6 and thymidine phosphorylase in breast cancer xenografts

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    19. Cunningham, D; Coleman, R
      New options for outpatient chemotherapy - the role of oral fluoropyrimidines

      CANCER TREATMENT REVIEWS
    20. Bertolini, A; Fiumano, M; Fusco, O; Muffatti, A; Scarinci, A; Pontiggia, G; Scopelliti, M
      Acute cardiotoxicity during capecitabine treatment: A case report

      TUMORI
    21. Suzuki, K; Morita, T; Hashimoto, S; Tokue, A
      Thymidine phosphorylase/platelet-derived endothelial cell growth factor (PD-ECGF) associated with prognosis in renal cell carcinoma

      UROLOGICAL RESEARCH
    22. Wang, MLH; Yung, WKA; Royce, ME; Schomer, DF; Theriault, RL
      Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    23. de Bono, JS; Twelves, CJ
      The oral fluorinated pyrimidines

      INVESTIGATIONAL NEW DRUGS
    24. Rauch, DP; Maurer, CA; Aebi, S; Pampallona, S; Friess, H; Ludwig, CU; Buchler, MW; Borner, MM
      Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancer

      ONCOLOGY
    25. Kono, T; Nishida, M; Inagaki, N; Tanaka, Y; Yoneda, M; Kasai, S
      Development and characterization of 1C6-203, a new monoclonal antibody specific to human thymidine phosphorylase

      JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
    26. Morita, T; Mitsuzaki, A; Tokue, A
      Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA

      INTERNATIONAL JOURNAL OF CANCER
    27. Blum, JL; Dieras, V; Lo Russo, PM; Horton, J; Rutman, O; Buzdar, A; Osterwalder, B
      Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients

      CANCER
    28. Marchetti, S; Chazal, M; Dubreuil, A; Fischell, JL; Etienne, MC; Milano, G
      Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis

      BRITISH JOURNAL OF CANCER
    29. Leonard, RCF
      Oval fluoropyrimidines among the new drugs for patients with metastatic breast cancer

      BRITISH JOURNAL OF CANCER
    30. Papamichael, D
      The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: Current status

      STEM CELLS
    31. Di Costanzo, F; Sdrobolini, A; Gasperoni, S
      Capecitabine, a new oral fluoropyrimidine for the treatment of colorectal cancer

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    32. Kurosumi, M; Tabei, T; Suemasu, K; Inoue, K; Kusawake, T; Sugamata, N; Higashi, Y
      Enhancement of immunohistochemical reactivity for thymidine phosphorylase in breast carcinoma cells after administration of docetaxel as a neoadjuvant chemotherapy in advanced breast cancer patients

      ONCOLOGY REPORTS
    33. Mori, K; Hasegawa, M; Nishida, M; Toma, H; Fukuda, M; Kubota, T; Nagasue, N; Yamana, H; Chung, KHY; Ikeda, T; Takasaki, K; Oka, M; Kameyama, M; Toi, M; Fujii, H; Kitamura, M; Murai, M; Sasaki, H; Ozono, S; Makuuchi, H; Shimada, Y; Onishi, Y; Aoyagi, S; Mizutani, K; Ogawa, M; Nakao, A; Kinoshita, H; Tono, T; Imamoto, H; Nakashima, Y; Manabe, T
      Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues

      INTERNATIONAL JOURNAL OF ONCOLOGY
    34. Takiguchi, N; Nakajima, N; Saitoh, N; Fujimoto, S; Nakazato, H
      A phase III randomized study comparing oral doxifluridine and oral 5-fluorouracil after curative resection of gastric cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    35. Sobrero, A; Kerr, D; Glimelius, B; Van Cutsem, E; Milano, G; Pritchard, DM; Rougier, P; Aapro, M
      New directions in the treatment of colorectal cancer: a look to the future

      EUROPEAN JOURNAL OF CANCER
    36. Adjei, AA
      The Schilsky article reviewed

      ONCOLOGY-NEW YORK
    37. Napier, MP; Ledermann, JA
      Novel chemotherapeutic agents in colorectal cancer

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    38. Fujiwaki, R; Hata, K; Nakayama, K; Fukumoto, M; Miyazaki, K
      Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer

      JOURNAL OF CLINICAL ONCOLOGY
    39. Nemunaitis, J; Eager, R; Twaddell, T; Corey, A; Sekar, K; Tkaczuk, K; Thompson, J; Hoff, PM; Pazdur, R
      Phase I assessment of the pharmacokinetics, metabolism, and safety of emitefur in patients with refractory solid tumors

      JOURNAL OF CLINICAL ONCOLOGY
    40. Mani, S; Hochster, H; Beck, T; Chevlen, EM; O'Rourke, MA; Weaver, CH; Bell, WN; White, R; McGuirt, C; Levin, J; Hohneker, J; Schilsky, RL; Lokich, J
      Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancer

      JOURNAL OF CLINICAL ONCOLOGY
    41. Schuller, J; Cassidy, J; Dumont, E; Roos, B; Durston, S; Banken, L; Utoh, M; Mori, K; Weidekamm, E; Reigner, B
      Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    42. Ishitsuka, H
      Capecitabine: preclinical pharmacology studies

      INVESTIGATIONAL NEW DRUGS
    43. Budman, DR
      Capecitabine

      INVESTIGATIONAL NEW DRUGS
    44. Van Cutsem, E; Peeters, M
      Oral fluoropyrimidines in colorectal cancer

      SEMINARS IN ONCOLOGY
    45. Oevermann, K; Buer, J; Hoffmann, R; Franzke, A; Schrader, A; Patzelt, T; Kirchner, H; Atzpodien, J
      Capecitabine in the treatment of metastatic renal cell carcinoma

      BRITISH JOURNAL OF CANCER
    46. Pronk, LC; Vasey, P; Sparreboom, A; Reigner, B; Planting, AST; Gordon, RJ; Osterwalder, B; Verweij, J; Twelves, C
      A phase I and pharmacokinetic study of the combination of capecitabine anddocetaxel in patients with advanced solid tumours

      BRITISH JOURNAL OF CANCER
    47. Votruba, I; Krecmerova, M; Hrebabecky, H; Holy, A
      Inhibitory potency of 5-benzyluracil, 5-phenylcytosine and 5-phenylpyrimidin-2-one nucleosides against uridine phosphorylase from mouse leukemic L1210 cells

      NUCLEOSIDES & NUCLEOTIDES
    48. Cassidy, J; Twelves, C; Cameron, D; Steward, W; O'Byrne, K; Jodrell, D; Banken, L; Goggin, T; Jones, D; Roos, B; Bush, E; Weidekamm, E; Reigner, B
      Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    49. Morita, T; Tokue, A
      Biomodulation of 5-fluorouracil by interferon-alpha in human renal carcinoma cells: relationship to the expression of thymidine phosphorylase

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    50. Reigner, B; Clive, S; Cassidy, J; Jodrell, D; Schulz, R; Goggin, T; Banken, L; Roos, B; Utoh, M; Mulligan, T; Weidekamm, E
      Influence of the antacid Maalox on the pharmacokinetics of capecitabine incancer patients

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    51. Macdonald, JS
      Oral fluoropyrimidines - A closer look at their toxicities

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    52. Judson, IR; Beale, PJ; Trigo, JM; Aherne, W; Crompton, T; Jones, D; Bush, E; Reigner, B
      A human capecitabine excretion balance and pharmacokinetic study after administration of a single oral dose of C-14-labelled drug

      INVESTIGATIONAL NEW DRUGS
    53. Ishitsuka, H; Shimma, N; Horii, I
      Discovery and development of novel anticancer drug capecitabine

      YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    54. Brito, RA; Medgyesy, D; Zukowski, TH; Royce, ME; Ravandi-Kashani, F; Hoff, PM; Pazdur, R
      Fluoropyrimidines: A critical evaluation

      ONCOLOGY
    55. Verweij, J
      Rational design of new Tumoractivated (TM) cytotoxic agents

      ONCOLOGY
    56. Blum, JL
      Xeloda (R) in the treatment of metastatic breast cancer

      ONCOLOGY
    57. Marty, M; Espie, M; Cottu, PH; Cuvier, C; Lerebours, F
      Optimizing chemotherapy for patients with advanced breast cancer

      ONCOLOGY
    58. Cassidy, J
      Potential of Xeloda (R) in colorectal cancer and other solid tumors

      ONCOLOGY
    59. Diasio, RB
      Improving fluorouracil chemotherapy with novel orally administered fluoropyrimidines

      DRUGS
    60. MEROPOL NJ
      ORAL FLUOROPYRIMIDINES IN THE TREATMENT OF COLORECTAL-CANCER

      European journal of cancer
    61. ISHIKAWA T; FUKASE Y; YAMAMOTO T; SEKIGUCHI F; ISHITSUKA H
      ANTITUMOR ACTIVITIES OF A NOVEL FLUOROPYRIMIDINE, N-4-PENTYLOXYCARBONYL-5'-DEOXY-5-FLUOROCYTIDINE (CAPECITABINE)

      Biological & pharmaceutical bulletin
    62. Frings, S
      Capecitabine - a novel oral tumor-activated fluoropyrimidine

      ONKOLOGIE
    63. PUNT CJA
      NEW DRUGS IN THE TREATMENT OF COLORECTAL-CARCINOMA

      Cancer
    64. VONHOFF DD; GOODWIN AL; GARCIA L
      ADVANCES IN THE TREATMENT OF PATIENTS WITH PANCREATIC-CANCER - IMPROVEMENT IN SYMPTOMS AND SURVIVAL-TIME

      British Journal of Cancer
    65. ISHIKAWA T; UTOH M; SAWADA N; NISHIDA M; FUKASE Y; SEKIGUCHI F; ISHITSUKA H
      TUMOR SELECTIVE DELIVERY OF 5-FLUOROURACIL BY CAPECITABINE, A NEW ORAL FLUOROPYRIMIDINE CARBAMATE, IN HUMAN CANCER XENOGRAFTS

      Biochemical pharmacology
    66. BAJETTA E; CARNAGHI C; SOMMA L; STAMPINO CG
      A PILOT SAFETY STUDY OF CAPECITABINE, A NEW ORAL FLUOROPYRIMIDINE, INPATIENTS WITH ADVANCED NEOPLASTIC DISEASE

      Tumori


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 20:42:38